Cellebrite Investor Presentation — March 2024

Document content

For the three months ended

(Unaudited) (Unaudited)

Revenue 89,582 71,234

Gross profit 76,318 58,828

Gross margin 85.2% 82.6%

Operating income 9,247 136

Operating margin 10.3% 0.2 %

Net loss (71,372) (40,605)

Cash flow from operating activities 10,041 12,476

Non -GAAP Financial Data:

Operating income 15,879 5,653

Operating margin 17.7% 7.9%

Net income 16,866 6,899

Adjusted EBITDA 17,632 7,304

Adjusted EBITDA margin 19.7% 10.3%

For the three months ended

(Unaudited) (Unaudited)

Cost of revenues $ 13,264 $ 12,406

Share based compensation 430 386

Acquisition related costs 2 13

Non -GAAP cost of revenues $ 12,832 $ 12,007

For the three months ended

(Unaudited) (Unaudited)

Gross profit $ 76,318 $ 58,828

Share based compensation 430 386

Acquisition related costs 2 13

Non -GAAP gross profit $ 76,750 $ 59,227

For the three months ended

(Unaudited) (Unaudited)

Operating expenses $ 67,071 $ 58,692

Preview truncated — download the full document for the complete content.